Variant report
Variant | esv3366180 |
---|---|
Chromosome Location | chr5:91601896-91605094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534658094 | chr5:91601947-91601948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113753623 | chr5:91601957-91601958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193207797 | chr5:91601959-91601960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72777049 | chr5:91602012-91602013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs151055267 | chr5:91602141-91602142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574944350 | chr5:91602159-91602160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559859633 | chr5:91602229-91602230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35750559 | chr5:91602231-91602232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557293307 | chr5:91602244-91602245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577920616 | chr5:91602248-91602249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77934988 | chr5:91602290-91602291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185593820 | chr5:91602292-91602293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140130911 | chr5:91602298-91602299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149368515 | chr5:91602346-91602347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562961400 | chr5:91602368-91602369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531797076 | chr5:91602417-91602418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73131587 | chr5:91602472-91602473 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs563750498 | chr5:91602478-91602479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75572184 | chr5:91602514-91602515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146890693 | chr5:91602532-91602533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566575805 | chr5:91602560-91602561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190110860 | chr5:91602605-91602606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548849044 | chr5:91602629-91602630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140713708 | chr5:91602654-91602655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181613168 | chr5:91602678-91602679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557354752 | chr5:91602681-91602682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144618257 | chr5:91602777-91602778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565538776 | chr5:91602829-91602830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534259936 | chr5:91602925-91602926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554425617 | chr5:91602934-91602935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574191941 | chr5:91602971-91602972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73131588 | chr5:91602985-91602986 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs556746699 | chr5:91602988-91602989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115793404 | chr5:91603035-91603036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545482633 | chr5:91603065-91603066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574585261 | chr5:91603067-91603068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565312082 | chr5:91603126-91603127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149574965 | chr5:91603129-91603130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183907931 | chr5:91603199-91603200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540209929 | chr5:91603221-91603222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145451449 | chr5:91603230-91603231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561258801 | chr5:91603244-91603245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4403206 | chr5:91603258-91603259 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs548770748 | chr5:91603303-91603304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568684147 | chr5:91603313-91603314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531322424 | chr5:91603375-91603376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576550469 | chr5:91603410-91603411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543631058 | chr5:91603413-91603414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73773824 | chr5:91603432-91603433 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs570939276 | chr5:91603477-91603478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19592390 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:91601200-91604000 | Weak transcription | A549 | lung |
2 | chr5:91604000-91606000 | Enhancers | A549 | lung |
3 | chr5:91604000-91607200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr5:91604000-91607200 | Enhancers | Fetal Heart | heart |
5 | chr5:91604200-91605000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr5:91604200-91605400 | Enhancers | Fetal Lung | lung |
7 | chr5:91604200-91606400 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr5:91604400-91606600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr5:91604600-91605800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
10 | chr5:91604800-91605400 | Enhancers | NHDF-Ad | bronchial |